Bioclinica, an integrated solutions provider of clinical life science and technology expertise, has acquired Silicon Valley-based Saliency.   Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients. The integration will dramatically accelerate image QC and interpretation, enabling rapid development of digital diagnostics and digital therapeutics.   “Clients rely on us for time...